News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanguine Corporation (SGNC) Announces Additional Business Directives


9/17/2008 9:41:54 AM

PASADENA, CA--(Marketwire - September 17, 2008) - Sanguine Corporation (OTCBB: SGUI) is pleased to announce additional business directives aimed at focusing its PHER-O2 development objectives in other areas outside of synthetic blood. According to David Nelson, Sanguine's CFO, Sanguine has decided to target its primary efforts in three promising markets that it believes represent a much clearer path toward success.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES